|
C1QBP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.602500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.301900E-02 |
| Normal-vs-Stage2 |
6.882500E-02 |
| Normal-vs-Stage3 |
1.084140E-03 |
| Normal-vs-Stage4 |
6.06089999999337E-05 |
| Stage1-vs-Stage2 |
5.002500E-03 |
| Stage1-vs-Stage3 |
6.467800E-02 |
| Stage1-vs-Stage4 |
9.060700E-03 |
| Stage2-vs-Stage3 |
4.171500E-04 |
| Stage2-vs-Stage4 |
4.47679999999728E-05 |
| Stage3-vs-Stage4 |
2.249800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.396600E-03 |
| Normal-vs-AfricanAmerican |
1.398810E-01 |
| Normal-vs-Asian |
4.889600E-01 |
| Caucasian-vs-AfricanAmerican |
6.333800E-01 |
| Caucasian-vs-Asian |
1.205420E-01 |
| AfricanAmerican-vs-Asian |
5.123800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.802300E-02 |
| Normal-vs-Female |
5.518200E-02 |
| Male-vs-Female |
4.124800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.203600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.235200E-03 |
| Normal-vs-Age(61-80Yrs) |
7.572800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.242600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.319200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.941560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.535800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.542400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.711400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.778600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.079100E-03 |
| Classical-VS-Follicular |
3.02759999959434E-07 |
| Classical-VS-Other |
6.950600E-01 |
| Classical-VS-Normal |
7.352000E-04 |
| Tall-VS-Follicular |
9.9368002715039E-10 |
| Tall-VS-Other |
3.867000E-01 |
| Tall-VS-Normal |
1.84729999996858E-06 |
| Follicular-VS-Other |
4.499500E-03 |
| Follicular-VS-Normal |
1.326070E-02 |
| Other-VS-Normal |
5.419700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.574200E-01 |
| Normal-vs-N1 |
1.858430E-03 |
| N0-vs-N1 |
9.804300E-03 |
|
|
